TVA-Recherche.lu

TVA-Recherche à


Toutes les informations sur:

                        
Nom

Quantum Pharma Holdings Limited

Adresse
25 Bedford Square
Bloomsbury
WC1B 3HH
VAT ID (Numéro de TVA) no VAT ID available
Société Numéro de Registre 09269818 Show on Companies House
Accountsaudit-exemption-subsidiary
last accounts made up to 30 juin 2022
Activité (Code NAF)70100 - Activités des sièges sociaux
Statut de Sociétéactive
Noms Précédents
  • Quantum Pharma Holdings PLC
  • Quantum Pharma PLC
  • KYC Check
    KYC / PEP / AML request
    This data is incorrect?
    Source: Company Register: Companies House (companieshouse.gov.uk)

    Quick access

    Persons with Significant Control (1)

    Source: Companies House
    gb-flag GB Clinigen Limited Status: Active Notified: 01/11/2017 Companies House Number: 06771928 Nature of Control
  • Ownership of shares - 75% or more
  • Officers (5)

    Source: Companies House
    Adair, Richard Edward Bloomsbury, United Kingdom Status: Active Notified: 30/04/2024 Role: Secretary
    Charton, Jerome Marie Joseph Bloomsbury, United Kingdom Status: Active Notified: 30/04/2024 Occupation: Director Role: Director Country of Residence: Switzerland Nationality: Swiss
    Paling, Richard John Weybridge, Surrey, United Kingdom Status: Active Notified: 30/06/2018 Date of Birth: 04/1970 Occupation: Group Financial Controller Role: Director Country of Residence: England Nationality: British
    Bryant, David John Weybridge, United Kingdom Status: Ceased Notified: 30/06/2018 Ceased: 26/01/2024 Date of Birth: 02/1967 Occupation: Chief Business Officer Role: Director Country of Residence: Wales Nationality: British
    Swinhoe, Craig Robert Burnopfield Status: Ceased Notified: 01/11/2017 Ceased: 30/06/2018 Occupation: Managing Director Role: Director Country of Residence: United Kingdom Nationality: British

    Companies Controlled by This Company (1)

    gb-flag GB Quantum Pharma 2014 Limited Status: Active Notified: 04/11/2016 Companies House Number: 09269809 Nature of Control
  • Ownership of shares - 75% or more